LIFECARE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.965 NOK | -12.92% |
|
-20.62% | -33.52% |
| 04-26 | Lifecare to Take Majority Stake in Medical Technology Company RemovAid | MT |
| 04-26 | Lifecare Seeks Fresh Capital from Rights Offering | MT |
| Sales 2024 * | 8.7M 789K 1.07M | Sales 2025 * | 70.5M 6.39M 8.66M | Capitalization | 400M 36.27M 49.14M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 37.6 x |
| Net cash position 2024 * | 72.9M 6.61M 8.96M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 5.67 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 32 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.79% |
More Fundamentals
* Assessed data
More news
| 1 day | -12.92% | ||
| 1 week | -20.62% | ||
| Current month | +4.04% | ||
| 1 month | -0.84% | ||
| 3 months | -24.75% | ||
| 6 months | +19.56% | ||
| Current year | -33.52% |
1 week
2.90
3.90
1 month
2.796.32
Current year
2.666.32
1 year
1.426.32
3 years
1.156.32
5 years
0.589.00
10 years
0.589.00
| Managers | Title | Age | Since |
|---|---|---|---|
Joacim Holter
CEO | Chief Executive Officer | 48 | 10-12-31 |
Andreas Pfützner
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 21-05-07 | |
Bo Petersson
BRD | Director/Board Member | - | 20-11-19 |
Lutz Heinemann
BRD | Director/Board Member | - | 20-11-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 2.965 | -12.92% | 1,227,295 |
| 24-04-25 | 3.405 | 0.00% | 168,740 |
| 24-04-24 | 3.405 | -5.29% | 371,810 |
| 24-04-23 | 3.595 | -0.14% | 446,549 |
| 24-04-22 | 3.6 | -3.61% | 435,749 |
Real-time Oslo Bors, April 26, 2024 at 10:45 am
More quotes
Lifecare AS is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Calendar
2024-04-29
- Annual General Meeting
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.52% | 36.21M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- LIFE Stock
